Results

Total Results: 423 records

Showing results for "aspirin".

121. Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/use-decision-models-development-evidence-based-clinical-preventive-services-recommendations
     May 01, 2019 - The reviews discussed the effect of aspirin on cardiovascular and total mortality, the effect of aspirin … in reducing the incidence of CRC, and the harms of aspirin. 9 Whether the USPSTF uses models for a … Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. … Aspirin Use to Prevent Cardiovascular Disease and Cancer: A Decision Analysis. … Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms.

122. Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/EppFbhnDEX5UtYWrTkLEhT
     March 01, 2007 - Studies not shown but included were acetylsalicylic acid (ASA) studies or studies that considered more … acid NSAIDs, acetylsalicylic acid plus non–acetylsalicylic acid NSAIDs, or cyclooxygenase-2 inhibitors … acid NSAIDs or acetylsalicylic acid plus non–acetylsalicylic acid NSAIDs. … Cardiovascular Harms of Non–Acetylsalicylic Acid (ASA) Nonsteroidal Anti-inflammatory Drugs (NSAIDs) … ASA � acetylsalicylic acid; FAP � familial adenomatous polyposis; IBD � inflammatory bowel disease; NR

123. Eleventh Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/reports-congress/eleventh-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services
     January 01, 2021 - Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality   Recruit enough people from … greatest disease burden, such as Black people, to be able to determine the effectiveness of different aspirin … Assess the populations most likely to benefit from aspirin prophylaxis and what risk threshold and factors … Improve effective and equitable implementation of clinical guidelines for aspirin use in pregnancy. 

124. Announcements | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=5
     January 13, 2022 - Public Comment on Draft Recommendation Statement, Draft Evidence Review, and Draft Modeling Report: Aspirin … Use to Prevent Cardiovascular Disease 2021-10-12 Final Recommendation Statement: Aspirin

125. Recommendation: Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/peripheral-artery-disease-in-adults-screening-with-the-ankle-brachial-index
     July 10, 2018 - One study, Aspirin for Asymptomatic Atherosclerosis (N = 3350), enrolled men and women aged 50 to 75 … Two trials addressed the harms of aspirin treatment in asymptomatic persons. … bleeding events requiring hospitalization in the aspirin therapy vs placebo group (hazard ratio, 1.71 … Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. … Fowkes FG, Price JF, Stewart MC, et al; Aspirin for Asymptomatic Atherosclerosis Trialists.

126. Announcements | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=10
     April 07, 2020 - Visual Acuity and Glaucoma in Adults 2020-02-13 Public Comment on Draft Research Plan: Aspirin … Illicit Drug Use in Children, Adolescents, and Young Adults 2019-10-01 Final Research Plan: Aspirin

127. Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/acqA29t-vpgphFscNPEfG8
     January 01, 2020 - One study, Aspirin for Asymptomatic Atherosclerosis (N = 3350), enrolled men and women aged 50 to 75 … Two trials addressed the harms of aspirin treatment in asymp- tomatic persons. … bleeding events requiring hospitalization in the aspirin therapy vs placebo group (hazard ratio, 1.71 … Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. … Fowkes FG, Price JF, Stewart MC, et al; Aspirin for Asymptomatic Atherosclerosis Trialists.

128. Clinical Summary: Screening for Cardiovascular Disease Risk With Electrocardiography (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/tHHBn5j3PD_Bnjk7q6tACS
     June 05, 2018 - usually treated w ith a combination of diet and exercise modif ications, lipid-low ering medications, aspirin … In addition, the USPSTF recommends low -dose aspirin use in certain persons at increased risk of CVD

129. Clinical Summary: Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/uPbfDukSXmFDWq8FDwTgKj
     July 03, 2018 - risk for CVD are usually treated w ith a combination of diet and exercise modif ications, statins, aspirin … activity, screening for peripheral artery disease and CVD risk assessment w ith the ABI, and low -dose aspirin

130. Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/decision-modeling-for-uspstf_0.pdf
     July 01, 2016 - The reviews discussed the effect of aspirin on cardiovascular and total mortality, the effect of aspirin … in reducing the incidence of CRC, and the harms of aspirin (9). … Aspirin use for the primary prevention of cardiovascular disease and colo- rectal cancer: U.S. … Aspirin Use to Prevent Cardiovascular Disease and Cancer: A Decision Analysis. … Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms.

131. Screening for Asymptomatic Carotid Artery Stenosis: Clinician Summary of USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/qSDQ3BxkWx3WovAKL2vbr9
     February 01, 2021 - for the prevention of cardiovascular disease in adults without known cardiovascular risk factors • Aspirin … healthful-diet-and-physical-activity-for-cardiovascular-disease-prevention-in-adults-without-known-risk-factors-behavioral-counseling https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer

132. Update Existing Topic | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/public-comments-and-nominations/nominating-recommendation-statement-topics/update-an-existing-prevention-recommendation
     May 03, 2025 - - Select - Anxiety Disorders in Adults: Screening Anxiety in Children and Adolescents: Screening Aspirin … Use to Prevent Cardiovascular Disease: Preventive Medication Aspirin Use to Prevent Preeclampsia and

133. Archived: Peripheral Arterial Disease (PAD) and CVD in Adults: Risk Assessment with Ankle Brachial Index | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/peripheral-arterial-disease-pad-and-cvd-in-adults-risk-assessment-with-ankle-brachial-index-2013
     September 15, 2013 - One randomized trial found that aspirin did not reduce CVD events in patients with a low ABI 2 . … One study showed that low-dose aspirin treatment in asymptomatic patients with a low ABI may increase … Treatment Evidence shows that low-dose aspirin treatment in asymptomatic patients with a low ABI … Of those, 3350 were randomly assigned to aspirin therapy (100 mg/d) or placebo. … for Asymptomatic Atherosclerosis, which compared daily aspirin therapy with a placebo control.

134. Screening for Colorectal Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/xL4XwcPKXBfTWgY5ouzLzy
     May 01, 2021 - The USPSTF has made recommendations on aspirin use to prevent cardiovascular disease and colorectal cancer … www.uspreventiveservicestaskforce.org https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer

135. First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services - V | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/first-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services-v
     December 01, 2011 - Aspirin Use to Prevent Heart Attacks and Strokes in Adults Ages 80 Years and Older In 2009, the USPSTF … found good evidence that aspirin decreases the incidence of myocardial infarction in men and ischemic … strokes in women and recommended that primary care clinicians discuss aspirin use with middle-aged men … While aspirin use has significant benefits, it also has significant risks, including gastrointestinal … The USPSTF did not find enough evidence to balance the potential benefits and harms of aspirin use to

136. First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services - Appendix C | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/first-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services-appendix-c
     December 01, 2011 - Listing of All USPSTF Specific Recommendations as of September 2011 Grade Title A Aspirin … to Prevent Myocardial Infarction: Men Ages 45 to 79 Years The USPSTF recommends the use of aspirin … A Aspirin to Prevent Ischemic Stroke: Women Ages 55 to 79 Years The USPSTF recommends the use … of aspirin for women ages 55 to 79 years when the potential benefit of a reduction in ischemic strokes … the use of aspirin for stroke prevention in women younger than age 55 years.

137. Evidence Summary: Atrial Fibrillation: Screening With Electrocardiography | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/atrial-fibrillation-screening-with-electrocardiography
     August 07, 2018 - Eligible treatment studies compared warfarin, aspirin, or novel oral anticoagulants (NOACs) with placebo … Three RCTs evaluated warfarin, 30 , 33 , 34 1 evaluated aspirin, 35 and 2 (described in 3 articles) … The BAATAF trial allowed participants in the no treatment group to take aspirin, but use of aspirin or … All 6 RCTs described in KQ4 for benefits of warfarin or aspirin also reported harms ( Table 2 ). 29-35 … contributed by participants taking aspirin.

138. Archived: Evidence Summary: Atrial Fibrillation: Screening With Electrocardiography | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/atrial-fibrillation-screening-with-electrocardiography-august-2018
     August 07, 2018 - Eligible treatment studies compared warfarin, aspirin, or novel oral anticoagulants (NOACs) with placebo … Three RCTs evaluated warfarin, 30 , 33 , 34 1 evaluated aspirin, 35 and 2 (described in 3 articles) … The BAATAF trial allowed participants in the no treatment group to take aspirin, but use of aspirin or … All 6 RCTs described in KQ4 for benefits of warfarin or aspirin also reported harms ( Table 2 ). 29-35 … contributed by participants taking aspirin.

139. Announcements | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=26
     February 11, 2014 - Preventive Services Task Force Issues Final Research Plan for Aspirin Use for the Primary Prevention … of Cancer and Aspirin Use for the Primary Prevention of Cardiovascular Events 2013-10-18

140. High-Priority Evidence Gaps For Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/rtc2016rev_2%20(3).pdf
     December 01, 2016 - Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer 6. … ..............................................................................................19 Aspirin … (Grade B) The decision to initiate low-dose aspirin use for the primary prevention of CVD and CRC … Use to Prevent Cardiovascular Disease and Colorectal Cancer • Role of aspirin therapy in racial/ … ethnic subpopulations • Benefits and harms of aspirin therapy in adults younger than age 50 years